Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (12822)	12/23/1997 9:15:00 PM
From: David Bogdanoff	Read Replies (2) \| Respond to of 32384

RB: Regarding index funds and mutual funds taxable gains; imo the biotechs are in only those index funds which represent the broadest market and even in those cases index funds generally do not shuffle their holdings (unless stocks are added or deleted from the index) and so there is very little capital gains to pay on index funds. further, funds of all types do there capital gains distributions by Oct. 31, so there should be little of fund tax selling by mutual funds at year end. Imo the tax selling is being done by individuals in stocks like ligand. David